Close Menu
  • Home
  • Technology
  • Science
  • Space
  • Health
  • Biology
  • Earth
  • History
  • About Us
    • Contact Us
    • Privacy Policy
    • Disclaimer
    • Terms and Conditions
What's Hot

Florida Startup Beams Solar Power Across NFL Stadium in Groundbreaking Test

April 15, 2025

Unlocking the Future: NASA’s Groundbreaking Space Tech Concepts

February 24, 2025

How Brain Stimulation Affects the Right Ear Advantage

November 29, 2024
Facebook X (Twitter) Instagram
TechinleapTechinleap
  • Home
  • Technology
  • Science
  • Space
  • Health
  • Biology
  • Earth
  • History
  • About Us
    • Contact Us
    • Privacy Policy
    • Disclaimer
    • Terms and Conditions
TechinleapTechinleap
Home»Biology»How Activated T Cells Reprogram Prostate Tumor-Associated Macrophages
Biology

How Activated T Cells Reprogram Prostate Tumor-Associated Macrophages

October 16, 2024No Comments4 Mins Read
Share
Facebook Twitter LinkedIn Email Telegram

Researchers have discovered a fascinating interplay between immune cells in prostate tumors. Tumor-associated macrophages (TAMs) are known to suppress the anti-tumor activity of T cells in prostate cancer. However, this new study shows that when activated T cells interact with TAMs, they can actually reprogram the macrophages to become more pro-inflammatory and support T cell migration into the tumor. This dynamic, reciprocal relationship between T cells and TAMs could be an important target for future prostate cancer immunotherapies.

figure 1
Fig. 1

Prostate Tumors: A Challenging Microenvironment for Immune Cells

Prostate cancer has been notoriously difficult to treat with immunotherapies – drugs that harness the body’s own immune system to fight cancer. While immunotherapies have shown remarkable success against some cancers, they have had limited benefit for patients with prostate tumors. Researchers have long puzzled over why the prostate tumor microenvironment (TME) is so resistant to immune attack.

One key factor appears to be the presence of tumor-associated macrophages (TAMs). These immune cells, which are derived from monocytes, tend to adopt an immunosuppressive “M2-like” phenotype within prostate tumors. TAMs can block the ability of T cells – the immune cells that normally seek out and destroy cancer cells – from infiltrating and attacking the tumor.

Harnessing the Dynamic Interplay Between T Cells and TAMs

In this new study, researchers set out to better understand the complex relationship between TAMs and T cells in the prostate TME. Using a novel microfluidic cell culture platform called “Stacks”, they were able to create realistic 3D models of the prostate TME by combining tumor cells, macrophages, and T cells isolated from prostate cancer patients.

Surprisingly, the researchers found that when activated T cells were introduced into these TME models, they were able to “reprogram” the TAMs to become more pro-inflammatory and supportive of T cell migration into the tumor. Specifically, the activated T cells induced TAMs to increase their secretion of important chemokines like CXCL9, CXCL10, and CXCL11, which help attract T cells into the tumor.

figure 2
Fig. 2

A Reciprocal, Feedback Loop Between T Cells and TAMs

The relationship between the T cells and TAMs in this study was highly dynamic and reciprocal. Not only did the T cells reshape the TAM phenotype, but the reprogrammed TAMs also helped to further activate the T cells, creating a self-reinforcing feedback loop.

The researchers found that the T cell-mediated reprogramming of the TAMs was largely dependent on the T cells’ secretion of interferon-gamma (IFN-γ). When they blocked IFN-γ, they were able to prevent the TAMs from upregulating their pro-inflammatory factors.

These findings suggest that even in the notoriously immunosuppressive prostate TME, there is the potential to “reawaken” the anti-tumor capabilities of T cells by targeting the dynamic interaction between T cells and TAMs. Future immunotherapies that can tip this balance in favor of a more pro-inflammatory TME may be key to improving outcomes for prostate cancer patients.

Author credit: This article is based on research by Erika Heninger, Matthew Thomas Breneman, Emma Elizabeth Recchia, Sheena Catherine Kerr, Reyna Elvan Dogru, Marina Nasrin Sharifi, Aaron Matthew LeBeau, David Kosoff.


For More Related Articles Click Here

This article is made available under the Creative Commons Attribution 4.0 International License, which grants users the right to utilize, share, adapt, distribute, and reproduce the content in any medium or format, as long as they give proper credit to the original author(s) and the source, and provide a link to the Creative Commons license. The images or other third-party material in this article are also included under the same Creative Commons license, unless otherwise specified in the credit line. If the material is not covered by the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain direct permission from the copyright holder. To review the full terms of this license, please visit the Creative Commons website.
cancer immunotherapy CD4+ T cells interferon-gamma prostate cancer therapy tumor microenvironment tumor-associated macrophages
jeffbinu
  • Website

Tech enthusiast by profession, passionate blogger by choice. When I'm not immersed in the world of technology, you'll find me crafting and sharing content on this blog. Here, I explore my diverse interests and insights, turning my free time into an opportunity to connect with like-minded readers.

Related Posts

Biology

Copper Affects Important Seaweed Species

November 17, 2024
Biology

Burkholderia pseudomallei: Implications for Melioidosis Treatment

November 17, 2024
Science

New Treatment For Gastric Cancer

November 17, 2024
Biology

New method for cattle identification

November 16, 2024
Biology

Genetic Diversity of the Asteraceae Family

November 15, 2024
Biology

Aggressive Prostate Cancer Through Urinary Extracellular Vesicles

November 15, 2024
Leave A Reply Cancel Reply

Top Posts

Florida Startup Beams Solar Power Across NFL Stadium in Groundbreaking Test

April 15, 2025

Quantum Computing in Healthcare: Transforming Drug Discovery and Medical Innovations

September 3, 2024

Graphene’s Spark: Revolutionizing Batteries from Safety to Supercharge

September 3, 2024

The Invisible Enemy’s Worst Nightmare: AINU AI Goes Nano

September 3, 2024
Don't Miss
Space

Florida Startup Beams Solar Power Across NFL Stadium in Groundbreaking Test

April 15, 20250

Florida startup Star Catcher successfully beams solar power across an NFL football field, a major milestone in the development of space-based solar power.

Unlocking the Future: NASA’s Groundbreaking Space Tech Concepts

February 24, 2025

How Brain Stimulation Affects the Right Ear Advantage

November 29, 2024

A Tale of Storms and Science from Svalbard

November 29, 2024
Stay In Touch
  • Facebook
  • Twitter
  • Instagram

Subscribe

Stay informed with our latest tech updates.

About Us
About Us

Welcome to our technology blog, where you can find the most recent information and analysis on a wide range of technological topics. keep up with the ever changing tech scene and be informed.

Our Picks

Extending the Lifespan of Donor Organs: A Breakthrough in Partial Freezing Technology

November 2, 2024

Decoding the Road to Safety: Insights into Lebanon’s Traffic Injury Surveillance System

October 17, 2024

Unlocking the Future of Fetal Brain Imaging

November 2, 2024
Updates

The Downfall of the ‘Assembly Theory of Everything’

September 27, 2024

Predicting Vulnerable Plaque: A Breakthrough in Cardiovascular Health

October 18, 2024

Cranes Navigating the Shifting Sands of Climate Change

September 27, 2024
Facebook X (Twitter) Instagram
  • Homepage
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
  • Disclaimer
© 2025 TechinLeap.

Type above and press Enter to search. Press Esc to cancel.